Ravi A Madan (Ravi Madan)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Metastatic Renal Cell Carcinoma

Radical Prostatectomy

Magnetic Resonance

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ravi A Madan, Edwin M Posadas, Richard J Lee
Progression-free survival end points in prostate cancer: are we truly making progress. Nature reviews. Urology (2024)
Anthony V Serritella, Himisha Beltran, Tamara L Lotan, David J VanderWeele, Fatima Karzai, Ravi A Madan, Maha H A Hussain
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small. The oncologist (2024)
David J Einstein, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan
Reply to B. Tombal et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ravi A Madan, Evan Y Yu, Edwin M Posadas, Richard J Lee, Fatima Karzai, Peter L Choyke
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Ravi A Madan, Evan Y Yu, Edwin M Posadas, Richard J Lee, Fatima Karzai, Peter L Choyke
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ravi A Madan, Evan Y Yu, Edwin M Posadas, Richard J Lee, Fatima Karzai, Peter L Choyke
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Anthony V Serritella, Himisha Beltran, Tamara L Lotan, David J VanderWeele, Fatima Karzai, Ravi A Madan, Maha H A Hussain
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small. The oncologist 29 (3) (2024)
Karen A Autio, Celestia S Higano, Luke Nordquist, Leonard J Appleman, Tian Zhang, Xin-Hua Zhu, Hani Babiker, Nicholas J Vogelzang, Sandip M Prasad, Michael T Schweizer, Ravi A Madan, Stephane Billotte, Nora Cavazos, Orlaith Bogg, Ray Li, Kam Chan, Helen Cho, Megan Kaneda, I-Ming Wang, Jenny Zheng, Szu-Yu Tang, Robert Hollingsworth, Kenneth A Kern, Daniel P Petrylak
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer 11 (3) (2023)
Ravi A Madan, Fatima Karzai, David J VanderWeele, Heather H Cheng, Johann S de Bono
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marijo Bilusic, Nicole J Toney, Renee N Donahue, Susan Wroblewski, Matthew Zibelman, Pooja Ghatalia, Eric A Ross, Fatima Karzai, Ravi A Madan, William L Dahut, James L Gulley, Jeffrey Schlom, Elizabeth R Plimack, Daniel M Geynisman
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate cancer and prostatic diseases 25 (4) (2022)
Ravi A Madan, Esther Mena, Liza Lindenberg, Peter C Black
With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, Lisa M Cordes, Cindy H Chau, Cody J Peer, Susan Wroblewski, Alwin D R Huitema, Jan H M Schellens, James L Gulley, William L Dahut, William Douglas Figg, Ravi A Madan
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide. The oncologist 27 (9) (2022)
Moon S Chen, Richard J Lee, Ravi A Madan, Van M Ta Park, Susan M Shinagawa, Tracy Sun, Scarlett Lin Gomez
Charting a Path Towards Asian American Cancer Health Equity: A Way Forward. Journal of the National Cancer Institute 114 (6) (2022)
Peter Joseph DeMaria, Katherine Lee-Wisdom, Renee N Donahue, Ravi A Madan, Fatima Karzai, Angie Schwab, Claudia Palena, Caroline Jochems, Charalampos S Floudas, Julius Strauss, Jennifer L Marté, Jason Mark Redman, Eva Dombi, Brigitte Widemann, Borys Korchin, Tatiana Adams, Cesar Pico-Navarro, Christopher Heery, Jeffrey Schlom, James L Gulley, Marijo Bilusic
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer. Journal for immunotherapy of cancer 9 (9) (2022)
Ravi A Madan, Claudia Palena
Behind the IL-8 ball in prostate cancer. Nature cancer 2 (8) (2022)
Marijo Bilusic, Sheri McMahon, Ravi A Madan, Fatima Karzai, Yo-Ting Tsai, Renee N Donahue, Claudia Palena, Caroline Jochems, Jennifer L Marté, Charalampos S Floudas, Julius Strauss, Jason Redman, Houssein Abdul Sater, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, James L Gulley
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer 9 (3) (2021)
Ravi A Madan, Fatima Karzai, Renee N Donahue, Munjid Al-Harthy, Marijo Bilusic, Inger I Rosner, Harpreet Singh, Philip M Arlen, Marc R Theoret, Jennifer L Marté, Lisa M Cordes, Anna Couvillon, Amy Hankin, Moniquea Williams, Helen Owens, Sarah E Lochrin, Cindy H Chau, Seth Steinberg, William Douglas Figg, William Dahut, Jeffrey Schlom, James L Gulley
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer. Journal for immunotherapy of cancer 9 (3) (2021)
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward McClay, Jason M Redman, Houssein Abdul Sater, Renee N Donahue, Caroline Jochems, Elizabeth Lamping, Andrea Burmeister, Jennifer L Marté, Lisa M Cordes, Marijo Bilusic, Fatima Karzai, Laureen S Ojalvo, Genevieve Jehl, P Alexander Rolfe, Christian S Hinrichs, Ravi A Madan, Jeffrey Schlom, James L Gulley
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies. Journal for immunotherapy of cancer 8 (2) (2021)
Peter Joseph DeMaria, Marijo Bilusic, Deric M Park, Christopher R Heery, Renee N Donahue, Ravi A Madan, Mohammad Hadi Bagheri, Julius Strauss, Victoria Shen, Jennifer L Marté, Seth M Steinberg, Jeffrey Schlom, Mark R Gilbert, James L Gulley
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma. The oncologist 26 (5) (2021)
Shruti U Gandhy, Ravi A Madan, Jeanny B Aragon-Ching
The immunotherapy revolution in genitourinary malignancies. Immunotherapy 12 (11) (2020)
Jeanny B Aragon-Ching, Ravi A Madan
Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib. Cancer 126 (24) (2020)
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, Ravi A Madan, Joanna H Shih, Maria J Merino, Stephanie A Harmon, David J VanderWeele, Lisa M Cordes, Nicole V Carrabba, John R Bright, Nicholas T Terrigino, Guinevere Chun, Marijo Bilusic, Anna Couvillon, Amy Hankin, Monique N Williams, Rosina T Lis, Huihui Ye, Peter L Choyke, James L Gulley, Adam G Sowalsky, Baris Turkbey, Peter A Pinto, William L Dahut
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Liza Lindenberg, Esther Mena, Ismail Baris Turkbey, Joanna H Shih, Sarah E Reese, Stephanie A Harmon, Ilhan Lim, Frank Lin, Anita Ton, Yolanda L McKinney, Philip Eclarinal, Deborah E Citrin, William L Dahut, Ravi A Madan, Bradford J Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Peter Pinto, Janet F Eary, Peter C Black
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI. Radiology 296 (3) (2020)
Fatima Karzai, Ravi A Madan, William L Dahut
The World of Clinical Trial Development Post COVID-19: Lessons Learned from a Global Pandemic. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Ravi A Madan, Fatima H Karzai, Munjid Al Harthy, Daniel P Petrylak, Joseph W Kim, Philip M Arlen, Inger Rosner, Marc R Theoret, Lisa Cordes, Marijo Bilusic, Cody J Peer, Nancy A Dawson, Anna Couvillon, Amy Hankin, Moniquea Williams, Guin Chun, Helen Owens, Jennifer L Marte, Min-Jung Lee, Yusuke Tomita, Akira Yuno, Jane B Trepel, Sunmin Lee, Seth M Steinberg, James L Gulley, William D Figg, William L Dahut
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer. BJU international 127 (4) (2020)